Other
Application of dHACM
Application of dHACM is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed267%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Use of dHACM in the Treatment of Venous Leg Ulcers
NCT02011503
completednot_applicable
Amniotic Membrane in Total Knee Replacements to Reduce Scarring
NCT02088567
withdrawnnot_applicable
Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face
NCT01995604
Clinical Trials (3)
Showing 3 of 3 trials
NCT02011503Not Applicable
Use of dHACM in the Treatment of Venous Leg Ulcers
NCT02088567Not Applicable
Amniotic Membrane in Total Knee Replacements to Reduce Scarring
NCT01995604Not Applicable
Dehydrated Human Amnion/Chorion Membrane (dHACM) for Recovery After Fractionated Ablative CO2 Laser Resurfacing of the Face
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3